182
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Surgical Time and Postoperative Symptoms Study in Pterygium Excision and Amniotic Membrane Graft Using Celularity Triple Layer Dehydrated Amniotic Membrane

, , , &
Pages 1967-1974 | Received 06 Apr 2023, Accepted 20 Jun 2023, Published online: 11 Jul 2023
 

Abstract

Purpose

To evaluate a novel sutureless glueless technique using a triple-layer dehydrated amniotic membrane (TLDAM) for pterygia excisions in surgical time, postoperative pain, epiphora, irritation, and FBS.

Methods

Twenty eyes with pterygia underwent excision with mitomycin C. The conjunctival defect was closed with TLDAM placed on the dried scleral bed with the edges of the amniotic membrane tucked under the edges of the conjunctival defect. Surgical times were measured from injection of lidocaine to final placement of bandage contact lens. After a bandage contact lens was placed, the eye was patched until POD1. Patients graded self-administered questionnaires to rate pain, FBS, irritation, and epiphora on a scale of 1–5 (1-none; 5-severe) at POD1 and POW1.

Results

Surgical times ranged from 6:55 to 12:00, with mean of 8:29. Compared with a previous study of sutureless glueless methodology, the difference in mean surgical time was 11.9 (p < 0.0001). Mean questionnaire scores were as follows: POD1 pain 1.8, FBS 2.3, irritation 1.0, and epiphora 2.6; POW1 pain 1.5, FBS 1.6, irritation 1.6, and epiphora 1.6. Compared to previous studies, this technique showed significantly improved pain at POD1 (p=0.0086, p<0.0001, p<0.0001, p<0.0001) and POW1 (p=0.0002, p=0.0016, p<0.0001). Significant improvement in irritation and FBS was noted at POD1 and POW1. See Table 1 for full analysis.

Conclusion

The sutureless glueless technique using TLDAM is a safe and effective technique compared to current standard methods. There appears to be a significant benefit regarding surgical time and postoperative pain, irritation, epiphora, and FBS compared to previous studies.

Acknowledgment

The abstract of this paper was presented at ARVO 2022 as a poster presentation with interim findings. The poster’s abstract was published in ARVO Annual Meeting Abstract at IVOS Journal. In addition, an article by Vicente Diaz was published to Ophthalmology Times about this project.

Disclosure

Vicente Diaz, consultant for Celularity. The authors report no conflicts of interest in this work.

Additional information

Funding

There is no funding to report.